A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years [clinicaltrials:NCT00006509]
A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years [clinicaltrials:NCT00006509]
Bio2RDF identifier
NCT00006509
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00006509
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... ses that are specific to HIV.
brief title [clinicaltrials_vocabulary:brief-title]
A Study of the Safety and Effe ...... HIV Drugs for at Least 2 Years
completion date [clinicaltrials_vocabulary:completion-date]
2007-06-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
HIV-infected patients t ...... c responses will be measured.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-11-17T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
AIDS Vaccines
Anti-HIV Agents
HIV Envelope Protein gp160
HIV Therapeutic Vaccine
Recombinant Proteins
Treatment Experienced
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-03-05T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00006509
official title [clinicaltrials_vocabulary:official-title]
A Phase I/II Safety and Immuno ...... erapy for a Minimum of 2 Years
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
GCRC M01-RR00102
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-03-01T00:00:00Z
identifier
clinicaltrials:NCT00006509
title
A Study of the Safety and Effe ...... HIV Drugs for at Least 2 Years
@en
type
label
A Study of the Safety and Effe ...... s [clinicaltrials:NCT00006509]
@en